Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2025 Earnings Call Transcript
Arrowhead Pharmaceuticals, Inc. ( NASDAQ: ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis - SVP & Head of Global Cardio/Metabolic Franchise James Hamilton - Chief Discovery & Translational Medicine Ken Myszkowski - CFO
Thank you for holding, and welcome to Rockwell Automation's quarterly conference call. I need to remind everyone that today's conference call is being recorded. (Operator Instructions) At this time, I ...
Edgewell Personal Care Co. (NYSE:EPC) reported its Q1 FY2025 earnings, revealing an earnings per share (EPS) of $0.07, falling short of the forecasted $0.12. The company's revenue also missed ...
This afternoon, Apple (AAPL) will report its earnings for the first quarter of the financial year. It will then host an ...
The specialty grocer said its debut of 23 new private label goods was a significant driver in its earnings results.
Comtech Telecommunications (NASDAQ:CMTL) Corp. reported a significant earnings miss for Q1 2025, with actual EPS at -$1.27 compared to a forecast of -$0.39. The company's revenue also fell short ...
Qualcomm’s Q1 2025 earnings call will take place today at 1:45 p.m. PT/4:45 p.m. ET. We’ll be streaming it on the Shacknews ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback